IRCT201207013043N6已完成2 期
Evaluation of protective effects of silymarin on cisplatin induced nephrotoxicity in patients with upper gastrointestinal adenocarcinoma
tehran university of medical science,0 个研究点目标入组 58 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 58
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 139 years（—）
- 性别
- All
入选标准
- •inclusion criteria (age>18 years; diagnosed and measurale upper gasterointestinal adenocarcinoma; no swallow problem; would like to participate in the study; GFR>45ml/min/1.73m2) Exclusion criteria( end stage renal disease, requiring dialysis, post transplantation; receiving contrast media during last 72 hours; chronic use of corticosteroids; chronic use of ACEI; untreated hypo-and hyperthyroidism; ejection fraction<60%; active urinary tract infection; iver disease (5fold increase of liver enzyme in asymptomatic or 3 fold increase in syptomatic; ; use of other nephrotoxic agents such as aminoglycoside, amphotricin; karnofsky performance status <70)
排除标准
- 未提供
研究者
相似试验
招募中
3 期
Protective effect of oral nano-silymarin on vancomycin-induced nephrotoxicity????????????? ???????????.IRCT20200408046990N9Mashhad University of Medical Sciences60
招募中
3 期
Evaluating the effectiveness of Silymarin on the prevention of gentamicin nephrotoxicityGentamicin-induced renal toxicity in hospitalized patients.Other bacterial diseasesA30-A49IRCT20161010030246N3Shiraz University of Medical Sciences60
尚未招募
3 期
Effect of silymarin in the treatment of patients with depressioIRCT20160804029191N4Mashhad University of Medical Sciences80
尚未招募
2 期
Silymarin capsule in COVID-19COVID-19 disease.COVID-19U07.1IRCT20180103038199N10Mashhad University of Medical Sciences140
已完成
2 期
Evaluation of the effects of silymarin and calciferol on LUTS in patients with benign prostatic hyperplasiaIRCT20200906048641N1Islamic Azad University60